Literature DB >> 27073435

Analysis of clinical value of CT in the diagnosis of pediatric pneumonia and mycoplasma pneumonia.

Liang Gong1, Chong-Lin Zhang1, Qing Zhen1.   

Abstract

Pneumonia is an infectious disease of the lung causing mortality. Mycoplasma pneumonia (MP) is an atypical bacterial pneumonia that damages several organs. Lung computed tomography (CT) has been utilized in its identification. The aim of the present study was to examine the value of computed tomography diagnosis for pediatric MP. The present study prospectively analyzed the clinical and imaging data of 1,280 cases of pediatric MP in the out- and inpatient departments from March, 2010 to March, 2014; analyzed the morphology and distribution of the pneumonic lesion in the lungs; and summarized the value of CT diagnosis for pediatric MP. In the included children, there were 688 cases of lesions in the unilateral lobe, 592 cases of lesions in the bilateral lobes, 1,101 cases of extensive patchy opacity, 496 cases of mottled opacity, 432 cases of increased lung marking, 256 cases of streak opacity, 192 cases of ground-glass opacity, 992 cases of thickened bronchial wall in the lesions, 128 cases of lymphadenopathy in the hilar lymph nodes and mediastinal lymph nodes, and the lung CT showed 32 cases of pulmonary cavity and 144 cases of pleural effusion. In conclusion, the CT signals of pediatric MP had several types with some children exhibiting complicated changes. The child's clinical manifestation and symptoms should thus be considered in the diagnosis to improve the diagnostic rate.

Entities:  

Keywords:  clinical value; computed tomography diagnosis; mycoplasma pneumonia; pediatric pneumonia

Year:  2016        PMID: 27073435      PMCID: PMC4812519          DOI: 10.3892/etm.2016.3073

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


Introduction

Pneumonia is a lung infection caused by a variety of germs, including viruses, bacteria, fungi and parasites (1). Symptoms of pneumonia vary depending on child's age and the cause of the pneumonia. The main symptoms include sore throat, headache, cough and fever (1,2). Pneumonia is a major infectious disease responsible for significant morbidity and mortality worldwide. Pneumonia caused by mycoplasma bacteria is a less serious form of infection (3). The child's secretion sputum is contagious and spreads easily in children. Mycoplasma pneumonia (MP) is a form of atypical bacterial pneumonia that damages several organs and systems through local infection of the respiratory tract. It was extensively spread in children with an increasing morbidity and is rapidly developing into a prevalent disease (4–6). A chest X-ray is the optimal option for diagnosing pneumonia. However, this test may not be ideal to identify the cause of pneumonia. Clinical tests are not considered significant, therefore a lung computed tomography (CT) scan was necessary for the early diagnosis of the disease (7). The diagnosis of pediatric pneumonia should be performed based on the major clinical manifestations and corresponding CT examination of the children. The present study prospectively analyzed the clinical data of 1,280 children to assess the diagnostic value of CT examination in pediatric MP. Gaining understanding of the children's characteristic imaging data was beneficial to the clinical diagnosis and treatment of pediatric MP.

Materials and methods

General information

The current study included 1,280 children (680 males and 600 females) with pediatric MP in the out- and inpatient departments from March, 2010 to March, 2014. The age range of the patients was 3 months to 10 years, with a mean age of 4.3±1.8 years, while the range of disease course was 3–15 days, with a mean course of 8.9±2.1 days. The clinical manifestations of all the patients were paroxysmal cough and irritating cough. Most children were complicated with fever, expectoration, chest stuffiness, and pharyngolaryngitis to varying degrees. All the children met the diagnostic criteria of pediatric MP in practical pediatrics (8). The study was approved by the Ethics Committee of Xuzhou Children's Hospital (Jiangsu, China).

Inclusion criteria

Inclusion criteria for the study were: i) Age range 3 months to 12 years (6); ii) major clinical manifestations meeting the clinical diagnostic criteria, including cough, fever, loss of appetite, and moist rales in the lung; iii) disease course of 4–15 days; iv) having signed informed consent with the agreement of guardians and v) exclusion of children with bronchitis, asthma, and respiratory infection due to cold (9).

Examination methods

Whole lung scanning was performed from apex pulmonis to basis pulmonis with a Philips Brilliance 16-slice spiral CT (Philips Healthcare, DA Best, The Netherlands). The slice width and spacing were 5 mm, the pitch was 1.20, and the scanning time was 1.0 sec. The voltage was maintained at 120 kV, the constant at 80–160 mA, the mediastinal window was W450:L45, and the lung window was W1,000:L2,500. The vertical and coronal planes of the lesion were reconstructed spontaneously. CT scan with contrast was performed after the plain scan and the scan parameters were the same as with those of the plain scan. The contrast agent was iohexol, which was injected by a high-pressure injector at a rate of 1.5–3 ml/sec. The mean CT value of the margin and interior of the lesion was calculated. Children with poor compliance were orally administered with 3% chloral hydrate (1.5 ml/kg). Children requiring special care completed the examinations with the accompaniment of his/her parents'/guardians (10).

CT images

The location, size, shape, density, distribution, internal structure, margin of the lesion, pleural effusion, hilar lymph nodes and mediastinal lymph nodes from the lung and mediastinal window were observed. The imaging data of the lesion, lesion site, its adjacent tissue and organ lesions obtained from all the CT examinations were analyzed.

Observational measurements

The lung CT imaging data of all the children were observed. The number of lobe lesions, including the lesions in the unilateral and bilateral lobes, the number of lesions in the left and right lobes and the main imaging features of the lesion lobes were recorded (11).

Results

Analysis of the lung CT imaging data of the children

As shown in Table I, of all the children, there were 688 cases of unilateral lobe lesions, 592 cases of bilateral lobe lesions, including 338 cases of left upper lobe lesions, 416 cases of left lower lobe lesions, 370 cases of right upper lobe lesions, 240 cases of left middle lobe lesions, and 435 cases of right lower lobe lesions. The lesions were predominantly extensive patchy opacity, mottled opacity, increased lung marking, streak opacity and ground-glass opacity. In addition, there were 992 cases of thickened bronchial wall in the lesions, 128 cases of lymphadenopathy in hilar lymph nodes and mediastinal lymph nodes, and lung CT showed 32 cases of pulmonary cavity and 144 cases of pleural effusion.
Table I.

The analysis of the lung CT imaging data of the children (no., %)

CharacteristicsNo. (%)
Lesion distribution
  Lesion in unilateral lobe688 (53.8)
  Right upper lobe370 (28.9)
  Right middle lobe240 (18.8)
  Right lower lobe435 (34.0)
  Left upper lobe338 (26.4)
  Left lower lobe416 (32.5)
  Lesions in bilateral lobes592 (46.3)
Features of the CT imaging of the lesions
  Extensive patchy opacity1,101 (86.0)
  Mottled opacity496 (38.8)
  Increased lung marking432 (33.8)
  Streak opacity256 (20.0)
  Ground-glass opacity192 (15.0)
Other lung manifestations
  Thickened bronchial wall992 (77.5)
  Hilar and mediastinal lymphadenopathy128 (10.0)
  Pulmonary cavity32 (2.5)
  Pleural effusion144 (11.3)

CT, computed tomography.

The analysis of imaging features

In a case involving a female child ages 5-years and 11 months old, who was hospitalized due to fever and cough for 4 days, the diagnosis was bilateral pneumonia and predominantly pneumonia in the upper lobe of the right lung. As shown in Fig. 1, the major imaging features included extensive high-density opacity in the upper lobe of the right lung, with the sign of bronchial inflation, less uniform lesion density, blurry boundary and slight thickening of the adjacent pleura, flocculent opacity and small patchy opacity in the lower lobe of the right lung. Increased vascular bundles in the bilateral bronchi were observed albeit they were blurry. Trachea and bilateral primary bronchi were unobstructed. No obvious density was identified in the mediastinum, a thymus shadow was observed in the anterior superior mediastinum, no obvious abnormal shape and size of the heart shadow was identified and no clear free liquid was evident in the bilateral thoracic cavities. No obvious abnormality in the bilateral thoracic spine and ribs was evident, and the structure of the soft tissue in the chest wall was clear.
Figure 1.

The imaging of bilateral inflammation in the children.

Discussion

Pediatric MP is an infective respiratory disease common in children due to MP (12–14), accounting for approximately 50% of cases. However, the morbidity of this disease has been on the increase (15). This disease can damage various organs and affect the child's normal growth and development. The disease has a short incubation period with the main symptoms of manifesting at the early phase of this disease head pain, fever, cough and pharyngalgia. Pediatric MP is seasonal, occurring primarily in spring and autumn. The child's secreta such as body fluid and sputum become contagious. Extensive infection occurs when the mycoplasma is mutated, and even death may occur when the disease is severe (16–18). The X-ray imaging changes were identified as more significant than those of clinical manifestation (19,20). X-ray examination showed that at the early phase, the clinical manifestations of most children were interstitial pneumonia, increased lung marking, reticular opacity, and uniform blurry opacity or patchy opacity when the condition was worsened with most lesions being close to the hilus and predominantly in the lower lung. Extensive infiltration and solid changes were rare, with some children having hilar lymphadenopathy, while a few children had pleural effusion (21). In comparison with X-ray, CT examination determined bronchitis, mixed pathological changes, and interstitial pneumonia. Therefore, CT was usually used for the diagnosis of children. Increasing reports have focused on the use of CT in the diagnosis of pneumonia. Xinbo (22) analyzed the CT examinations of children with pediatric pneumonia and the results indicated that the lung lesions were predominantly unilateral, the proportion of solid infiltration lesions was high, and the lung bronchial wall was thickened while some children had pleural effusion and rare hilar lymphadenopathy (23,24). In the current study, analysis of the data indicated that: i) the CT imaging of pediatric MP was a mainly unilateral lesion (53.8%), and secondly bilateral lesion (46.3%). Thus, bilateral lesions were more prevalent with the lesion in the lower lobe being mostly prevalent in all parts of the lung (the incidence of bilateral lesions in the lower lobes was >30.0%.) ii) The CT imaging of pediatric MP indicated various types of lesions in the lung tissues, including extensive patchy opacity, mottled opacity, increased lung marking, streak opacity and ground-glass opacity, with extensive patchy opacity being the main lesion, accounting for 86.0% of cases. iii) Analysis of the CT imaging data of 1,280 children with pediatric MP indicated that the children had simple pathological lobe lesions as well as complicated lesions in adjacent intrathoracic organs, predominantly thickened bronchial wall (77.5%). Other signs were not significant and only identified in some children, including hilar and mediastinal lymphadenopathy, pulmonary cavity and pleural effusion. Therefore, a comprehensive diagnosis should be performed based on the major clinical manifestations and corresponding CT examinations of the children with pediatric MP. A differential diagnosis should be performed with other types of pneumonia to determine the clinical treatment option, achieve early treatment, improve the diagnostic and cure rates, and promote early recovery (25,26). In conclusion, the diagnosis of pediatric MP should be performed based on the major clinical manifestations and CT imaging data of the children with pediatric MP to accomplish early diagnosis and treatment. Understanding of the children's characteristic imaging data was beneficial to clinical diagnosis and treatment.
  19 in total

1.  A case of lethal hemolytic anemia associated with severe pneumonia caused by Mycoplasma pneumoniae.

Authors:  Li Gu; Xiukai Chen; Huiqiao Li; Jiuxin Qu; Miao Miao; Fei Zhou; Yanyan Zhu; Xu Wang; Chunlei Wang; Yingmei Liu; Wenxiong Li; Bin Cao
Journal:  Chin Med J (Engl)       Date:  2014       Impact factor: 2.628

2.  [Analysis of 23S rRNA of Mycoplasma pneumoniae detected from pediatric inpatients with community-acquired pneumonia in a regional hospital in Japan].

Authors:  Kazuhiro Horiba; Kensei Gotoh; Fumihiko Hattori; Suguru Takeuchi; Naoko Nishimura; Takao Ozaki; Kimiyasu Shiraki
Journal:  Kansenshogaku Zasshi       Date:  2014-09

3.  Mycoplasma pneumonia--associated mucocutaneous disease in children: dilemmas in classification.

Authors:  Brea Prindaville; Brandon D Newell; Amy J Nopper; Kimberly A Horii
Journal:  Pediatr Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.588

4.  Characteristics of respiratory syncytial virus-induced bronchiolitis co-infection with Mycoplasma pneumoniae and add-on therapy with montelukast.

Authors:  Sheng-Hua Wu; Xiao-Qing Chen; Xia Kong; Pei-Ling Yin; Ling Dong; Pei-Yuan Liao; Jia-Ming Wu
Journal:  World J Pediatr       Date:  2015-04-06       Impact factor: 9.186

5.  Does cervical ureaplasma/mycoplasma colonization increase the lower uterine segment bleeding risk during cesarean section among patients with placenta previa? A cross-sectional study.

Authors:  P Aydogan; S Kahyaoglu; S Saygan; O Kaymak; L Mollamahmutoglu; N Danisman
Journal:  Eur Rev Med Pharmacol Sci       Date:  2014-08       Impact factor: 3.507

Review 6.  Beneficial effects of statins on outcomes in pneumonia: a systematic review and meta-analysis.

Authors:  H-H Cheng; T-T Tang; Q He; L-J Huang; X-L Lin; M Chen; C Yang; D-F Geng; S-P Jiang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2014-08       Impact factor: 3.507

7.  Mycoplasma pneumoniae infection with neurologic complications.

Authors:  Sevgi Yimenicioğlu; Ayten Yakut; Arzu Ekici; Kursat Bora Carman; Ener Cagrı Dinleyici
Journal:  Iran J Pediatr       Date:  2014-07-27       Impact factor: 0.364

8.  Cytokine response in pediatric patients with pandemic influenza H1N1 2009 virus infection and pneumonia: comparison with pediatric pneumonia without H1N1 2009 infection.

Authors:  Yeo Hyang Kim; Jung-Eun Kim; Myung Chul Hyun
Journal:  Pediatr Pulmonol       Date:  2011-05-27

9.  Decreased interleukin-18 response in asthmatic children with severe Mycoplasma pneumoniae pneumonia.

Authors:  Hai Lee Chung; Jin Young Shin; Mi Ju; Woo Taek Kim; Sang Gyung Kim
Journal:  Cytokine       Date:  2011-02-26       Impact factor: 3.861

10.  Mycoplasma pneumoniae Monoclonal P1 Type 2c Outbreak, Russia, 2013.

Authors:  Inna Edelstein; Svetlana Rachina; Arabella Touati; Roman Kozlov; Nadège Henin; Cécile Bébéar; Sabine Pereyre
Journal:  Emerg Infect Dis       Date:  2016-02       Impact factor: 6.883

View more
  5 in total

Review 1.  Atypical Pneumonia: Updates on Legionella, Chlamydophila, and Mycoplasma Pneumonia.

Authors:  Lokesh Sharma; Ashley Losier; Thomas Tolbert; Charles S Dela Cruz; Chad R Marion
Journal:  Clin Chest Med       Date:  2016-12-24       Impact factor: 2.878

2.  Diagnostic Value of Multi-Slice Spiral Computed Tomography for Bronchial Dysplasia in Premature Infants.

Authors:  Weiwei Zhang; Shaohua Wang
Journal:  Med Sci Monit       Date:  2018-10-15

3.  Effect of pidotimod combined with azithromycin on children with mycoplasma pneumonia and the expression levels of IL-10 and G-CSF in serum.

Authors:  Hongxing Shi; Limin Lan; Xianghong Lv; Lizhi Sun
Journal:  Exp Ther Med       Date:  2019-07-03       Impact factor: 2.447

4.  Differences in Clinical and Imaging Presentation of Pediatric Patients with COVID-19 in Comparison with Adults.

Authors:  Amei Chen; Jun-Xiang Huang; Yuting Liao; Zaosong Liu; Dandan Chen; Chongzhe Yang; Rui-Meng Yang; Xinhua Wei
Journal:  Radiol Cardiothorac Imaging       Date:  2020-04-06

5.  CT imaging changes of corona virus disease 2019(COVID-19): a multi-center study in Southwest China.

Authors:  Xiaoming Li; Wenbing Zeng; Xiang Li; Haonan Chen; Linping Shi; Xinghui Li; Hongnian Xiang; Yang Cao; Hui Chen; Chen Liu; Jian Wang
Journal:  J Transl Med       Date:  2020-04-06       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.